4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-001496
CHIEF OPERATING OFFICER sold 14,000 shares at an average $18.24 ($255,413)
- CHIEF OPERATING OFFICER acquired 7,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tessari Eben CHIEF OPERATING OFFICER | 2025-01-13 | Option exercise 10b5-1 | +7,000 | $3.80 | $26,600 | 102,975 | D |
| Tessari Eben CHIEF OPERATING OFFICER | 2025-01-13 | Sale 10b5-1 | −12,323 | $18.13 | $223,416 | 90,652 | D |
| Tessari Eben CHIEF OPERATING OFFICER | 2025-01-13 | Sale 10b5-1 | −1,677 | $19.08 | $31,997 | 88,975 | D |
| Derivatives | |||||||
| Tessari Eben CHIEF OPERATING OFFICER | 2025-01-13 | Option exercise · Share Option 10b5-1 | −7,000 | 28,049 | D | ||
| Open-market sales · 14,000 sh · avg $18.24 · $255,413 | |||||||
Loading xslF345X05/form4-01152025_090106.xml…